| |
| | CLINICAL FEATURES AND STAGING OF KAPOSI'S SARCOMA |
 | | In addition, the current status of staging systems for KS are discussed and recommendations are made for improving the staging of KS. |
 | | The most widely used staging system is the New York University system, which recognizes four stages: Stage I, cutaneous, locally indolent; Stage II, cutaneous, locally aggressive, with or without regional lymph nodes; Stage III, generalized mucocutaneous and/or lymph node involvement; and Stage IV, visceral. |
 | | Despite its wide use, this staging system, like others, has several limitations; it is recommended that a staging system be developed and validated that separates pts as to tumor burden, systemic signs, and absolute number of T-helper cells. |
| www.aegis.com /aidsline/1989/apr/M8940675.html (440 words) |
|